GALWAY, Ireland--(BUSINESS WIRE)--Aerogen, the global leader in aerosol drug delivery, today announced details of a broad collaborative effort to support pharmaceutical companies from around the world ...

The Irish Medtech Association revealed several winners at this year’s Irish Medtech Awards, including Aerogen and Medtronic. Galway-based Aerogen was named the grand prize winner at this year’s Irish ...

CanSinoBio said its inhaled vaccine uses a smaller dose, making it more cost effective to vaccinate a larger number of people worldwide. Galway medtech Aerogen has partnered with a Chinese pharma ...

The Aerogen Solo is a closed-system, single-patient-use aerosol drug delivery technology. (Business Wire/Aerogen) () After months of collaborative work in the lab, China's CanSino Biologics and Irish ...

GALWAY, Ireland--(BUSINESS WIRE)--Aerogen, the world leader in acute care aerosol drug delivery, today announced that Temasek, a global investment company headquartered in Singapore, has acquired a ...

MOUNTAIN VIEW, Calif. -- Aerogen, Inc. announces that a Phase 2 multi-center study evaluating an aerosolized antibiotic for treatment of ventilator-associated pneumonia (VAP) in the critical care ...

Galway-based medical device company Aerogen is to licence out its nebuliser technology to Dutch electronics giant Philips. The financial details of the transaction were not disclosed but it is known ...

Following months of collaborative development work, Aerogen ® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply ...

Galway-based medtech company Aerogen is playing a key role in the development of more than 15 potential therapies for Covid-19, including a promising inhaled interferon treatment. Hospitals around the ...

Aerogen, an Ireland-based global leader in acute-care aerosol drug delivery, and Indian Association of Respiratory Care (IARC) signed a MoU to enhance respiratory therapy education and improve patient ...

Two weeks after launch, 91% of people had confirmed that they had completed the training. That level of visibility simply wasn’t possible for us before.” — Daniel Burgess, Aerogen Pharma SAN MATEO, CA ...

The license agreement provides Nuance Pharma exclusive rights to develop and commercialize AeroFact for treatment of Respiratory Distress Syndrome (RDS) in all of Greater China. Mark G. Lotter, Chief ...